搜尋結果
US FDA tightens scrutiny of lab-developed tests with new rule
Reuters· 10 小時前For years, the agency had allowed labs to use their in-house tests to diagnose a range of ...
Data Activists Target OpenAI In Challenge To ChatGPT’s ‘Hallucination’ Problem
Forbes· 23 小時前For example, the group said ChatGPT gave “various inaccurate information” when asked about the ...
Sam Altman
Forbes· 15 小時前#2692 Sam Altman on the 2024 Billionaires - Sam Altman is the CEO of OpenAI and a prolific venture investor. In 2005, he dropped out of Stanford to found
ChatGPT's 'hallucination' problem hit with another privacy complaint in EU
TechCrunch· 21 小時前OpenAI is facing another privacy complaint in the European Union. This one, which has been ...